Both in Pharmaceuticals
Aclaris Therapeutics vs Neurogene
Over the past year ACRS returned +47.5% and NGNE returned −12.1%; their daily moves had a correlation of 0.21.
ACRS +47.5% NGNE −12.1%Growth of $1, one year, split-adjusted
| Metric | ACRS | NGNE |
|---|---|---|
| Price | $3.78 | $27.29 |
| Market cap | $585.1M | $546.1M |
| Today | −0.66% | +2.56% |
| 1 month | −11.6% | +3.1% |
| 6 months | −20.5% | −5.7% |
| Year to date | +25.4% | +32.5% |
| 1 year | +49.8% | −20.3% |
| Revenue growth (YoY) | −8.3% | — |
| Gross margin | 86.6% | — |
| Net margin | −1320.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 71.2× | — |
| Net cash | $91.6M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 76.5% |
| Short % of float | 12.4% | 39.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).